TY - STD TI - Ansseau M, Reggers J, Nickels J, Magerus S: Epidémiologie des troubles psychiatriques dans la province de Luxembourg, Plate-forme de concertation Psychiatrique, Université de Liège, Belgique. ID - ref1 ER - TY - JOUR AU - Kringlen, E. AU - Torgersen, S. AU - Cramer, V. PY - 2001 DA - 2001// TI - A Norwegian psychiatric epidemiological study JO - Am J Psychiatry VL - 158 UR - https://doi.org/10.1176/appi.ajp.158.7.1091 DO - 10.1176/appi.ajp.158.7.1091 ID - Kringlen2001 ER - TY - JOUR AU - Iancu, I. AU - Levin, J. AU - Hermesh, H. AU - Dannon, P. AU - Poreh, A. AU - Ben-Yehuda, Y. AU - Kaplan, Z. AU - Marom, S. AU - Kotler, M. PY - 2006 DA - 2006// TI - Social phobia symptoms: prevalence, sociodemographic correlates, and overlap with specific phobia symptoms JO - Compr Psychiatry VL - 47 UR - https://doi.org/10.1016/j.comppsych.2006.01.008 DO - 10.1016/j.comppsych.2006.01.008 ID - Iancu2006 ER - TY - JOUR AU - Blanco, C. AU - Raza, M. S. AU - Schneier, F. R. AU - Liebowitz, M. R. PY - 2003 DA - 2003// TI - The evidence-based pharmacological treatment of social anxiety disorder JO - Int J Neuropsychopharmacol VL - 6 UR - https://doi.org/10.1017/S1461145703003791 DO - 10.1017/S1461145703003791 ID - Blanco2003 ER - TY - JOUR AU - Davidson, J. AU - Yaryura-Tobias, J. AU - DuPont, R. AU - Stallings, L. AU - Barbato, L. M. AU - van der Hoop, R. G. AU - Li, D. PY - 2004 DA - 2004// TI - Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder JO - J Clin Psychopharmacol VL - 24 UR - https://doi.org/10.1097/01.jcp.0000106222.36344.96 DO - 10.1097/01.jcp.0000106222.36344.96 ID - Davidson2004 ER - TY - JOUR AU - Allgulander, C. PY - 1999 DA - 1999// TI - Paroxetine in social anxiety disorder: a randomized placebo-controlled study JO - Acta Psychiatr Scand VL - 100 UR - https://doi.org/10.1111/j.1600-0447.1999.tb10845.x DO - 10.1111/j.1600-0447.1999.tb10845.x ID - Allgulander1999 ER - TY - JOUR AU - Baldwin, D. S. AU - Bobes, J. AU - Stein, D. J. AU - Scharwachter, I. AU - Faure, M. PY - 1999 DA - 1999// TI - A randomised, double-blind, placebo-controlled study of paroxetine in the treatment of social phobia/social anxiety disorder JO - Br J Psychiatry VL - 175 UR - https://doi.org/10.1192/bjp.175.2.120 DO - 10.1192/bjp.175.2.120 ID - Baldwin1999 ER - TY - JOUR AU - Lydiard, R. B. AU - Bobes, J. PY - 2000 DA - 2000// TI - Therapeutic advances: paroxetine for the treatment of social anxiety disorder JO - Depress Anxiety VL - 11 UR - https://doi.org/3.0.CO;2-Z DO - 3.0.CO;2-Z ID - Lydiard2000 ER - TY - JOUR AU - Stein, M. B. AU - Chartier, M. J. AU - Hazen, A. L. AU - Kroft, C. D. AU - Chale, R. A. AU - Cote, D. AU - Walker, J. R. PY - 1996 DA - 1996// TI - Paroxetine in the treatment of generalised social phobia: open-label treatment and double-blind, placebo-controlled discontinuation JO - J Clin Psychopharmacol VL - 16 UR - https://doi.org/10.1097/00004714-199606000-00005 DO - 10.1097/00004714-199606000-00005 ID - Stein1996 ER - TY - JOUR AU - Stein, D. J. AU - Versiani, M. AU - Hair, T. AU - Kumar, R. PY - 2002 DA - 2002// TI - Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study JO - Arch Gen Psychiatry VL - 59 UR - https://doi.org/10.1001/archpsyc.59.12.1111 DO - 10.1001/archpsyc.59.12.1111 ID - Stein2002 ER - TY - JOUR AU - Van Ameringen, M. AU - Mancini, C. AU - Pipe, B. AU - Bennett, M. PY - 2004 DA - 2004// TI - Optimizing treatment in social phobia: a review of treatment resistance JO - CNS Spectr VL - 9 ID - Van Ameringen2004 ER - TY - JOUR AU - Atmaca, M. AU - Kuloglu, M. AU - Tezcan, E. AU - Unal, A. PY - 2002 DA - 2002// TI - Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings JO - Hum Psychopharmacol VL - 17 UR - https://doi.org/10.1002/hup.436 DO - 10.1002/hup.436 ID - Atmaca2002 ER - TY - JOUR AU - Varia, I. M. AU - Cloutier, C. A. AU - Doraiswamy, P. M. PY - 2002 DA - 2002// TI - Treatment of social anxiety disorder with citalopram JO - Prog Neuropsychopharmacol Biol Psychiatry VL - 26 UR - https://doi.org/10.1016/S0278-5846(01)00236-6 DO - 10.1016/S0278-5846(01)00236-6 ID - Varia2002 ER - TY - JOUR AU - Simon, N. M. AU - Korbly, N. B. AU - Worthington, J. J. AU - Kinrys, G. AU - Pollack, M. H. PY - 2002 DA - 2002// TI - Citalopram for Social Anxiety Disorder: An Open-label Pilot Study in Refractory and Nonrefractory Patients JO - CNS Spectr VL - 7 ID - Simon2002 ER - TY - JOUR AU - Shlik, J. AU - Maron, E. AU - Tru, I. AU - Aluoja, A. AU - Vasar, V. PY - 2004 DA - 2004// TI - Citalopram challenge in social anxiety disorder JO - Int J Neuropsychopharmacol VL - 7 UR - https://doi.org/10.1017/S146114570300405X DO - 10.1017/S146114570300405X ID - Shlik2004 ER - TY - JOUR AU - Sanchez, C. AU - Gruca, P. AU - Bien, E. AU - Papp, M. PY - 2003 DA - 2003// TI - R-citalopram counteracts the effect of escitalopram in a rat conditioned fear stress model of anxiety JO - Pharmacol Biochem Behav VL - 75 UR - https://doi.org/10.1016/S0091-3057(03)00165-5 DO - 10.1016/S0091-3057(03)00165-5 ID - Sanchez2003 ER - TY - JOUR AU - El Khoury, A. AU - Gruber, S. H. AU - Mork, A. AU - Mathe, A. A. PY - 2006 DA - 2006// TI - Adult life behavioral consequences of early maternal separation are alleviated by escitalopram treatment in a rat model of depression JO - Prog Neuropsychopharmacol Biol Psychiatry VL - 30 UR - https://doi.org/10.1016/j.pnpbp.2005.11.011 DO - 10.1016/j.pnpbp.2005.11.011 ID - El Khoury2006 ER - TY - JOUR AU - Lepola, U. M. AU - Loft, H. AU - Reines, E. H. PY - 2003 DA - 2003// TI - Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care JO - Int Clin Psychopharmacol VL - 18 UR - https://doi.org/10.1097/00004850-200307000-00003 DO - 10.1097/00004850-200307000-00003 ID - Lepola2003 ER - TY - JOUR AU - Wade, A. AU - Friis Andersen, H. PY - 2006 DA - 2006// TI - The onset of effect for escitalopram and its relevance for the clinical management of depression JO - Curr Med Res Opin VL - 22 UR - https://doi.org/10.1185/030079906X148319 DO - 10.1185/030079906X148319 ID - Wade2006 ER - TY - JOUR AU - Lader, M. AU - Stender, K. AU - Burger, V. AU - Nil, R. PY - 2004 DA - 2004// TI - Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: randomised, double-blind, placebo-controlled, fixed-dose study JO - Depress Anxiety VL - 19 UR - https://doi.org/10.1002/da.20014 DO - 10.1002/da.20014 ID - Lader2004 ER - TY - JOUR AU - Kasper, S. AU - Stein, D. J. AU - Loft, H. AU - Nil, R. PY - 2005 DA - 2005// TI - Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study JO - Br J Psychiatry VL - 186 UR - https://doi.org/10.1192/bjp.186.3.222 DO - 10.1192/bjp.186.3.222 ID - Kasper2005 ER - TY - JOUR AU - Goodman, W. K. AU - Bose, A. AU - Wang, Q. PY - 2005 DA - 2005// TI - Treatment of generalized anxiety disorder with escitalopram: pooled results from double-blind, placebo-controlled trials JO - J Affect Disord VL - 87 UR - https://doi.org/10.1016/j.jad.2004.11.011 DO - 10.1016/j.jad.2004.11.011 ID - Goodman2005 ER - TY - JOUR AU - Stein, D. J. AU - Andersen, E. W. AU - Lader, M. PY - 2005 DA - 2005// TI - Escitalopram for the treatment of GAD: efficacy across different subgroups and outcomes JO - Ann Clin Psychiatry VL - 17 UR - https://doi.org/10.1080/10401230590932335 DO - 10.1080/10401230590932335 ID - Stein2005 ER - TY - JOUR AU - Spadone, C. PY - 2002 DA - 2002// TI - Effects of escitalopram on anxiety symptoms in depression JO - Encephale VL - 28 ID - Spadone2002 ER -